Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 576Carcinoma, Non-Small-Cell Lung 490Ovarian Neoplasms 328Lung Neoplasms 208Fallopian Tube Neoplasms 153Neoplasms 152Stomach Neoplasms 128Esophageal Neoplasms 127Triple Negative Breast Neoplasms 125Neoplasm Metastasis 120Carcinoma, Ovarian Epithelial 115Squamous Cell Carcinoma of Head and Neck 96Endometrial Neoplasms 95Uterine Cervical Neoplasms 80Head and Neck Neoplasms 78Esophageal Squamous Cell Carcinoma 76Adenocarcinoma of Lung 49Recurrence 48Parkinson Disease 4, Autosomal Dominant Lewy Body 45Melanoma 42Carcinoma 42Urinary Bladder Neoplasms 41Adenocarcinoma Of Esophagus 36Small Cell Lung Carcinoma 34Carcinoma, Squamous Cell 34Prostatic Neoplasms 32Pancreatic Neoplasms 30Breast Neoplasms, Male 28Unspecified Adult Solid Tumor, Protocol Specific 27Adenocarcinoma, Bronchiolo-Alveolar 26

Interventions

Pemetrexed 8Carboplatin 6Cisplatin 4Bevacizumab 4pembrolizumab 3anlotinib 3Platinum 2Paclitaxel 2tusamitamab ravtansine 1ixabepilone 1icotinib 1endostar protein 1camrelizumab 1Gefitinib 1Erlotinib Hydrochloride 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Non-squamous Non-small Cell Lung Cancer × Paclitaxel × Clear all
NCT03329911 2021-09-14

A Comparative Study of BAT1706 and EU AvastinĀ® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer

Bio-Thera Solutions

Phase 3 Completed
651 enrolled 10 charts
Thoracic

Non-squamous Non-small Cell Lung Cancer

NCT03169335 2018-08-24

Efficacy and Safety of QL1101 and AvastinĀ® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer

Qilu Pharmaceutical Co., Ltd.

Phase 3 Completed
535 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚔